<DOC>
	<DOCNO>NCT03037281</DOCNO>
	<brief_summary>Nociceptin protein find body , number function central nervous system , blood vessel gut . There evidence may role control immune response infection , may act link brain immune system . In infection , surgery , increase nociceptin , subject great elevation nociceptin poor outcome . There evidence cell immune system may produce nociceptin , although yet know cell capable produce , `` switch '' production . This study aim determine 1 . Which cell immune system produce nociceptin 2 . If difference ability produce nociceptin healthy volunteer patient severe infection</brief_summary>
	<brief_title>Release Nociceptin From Granulocytes Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<mesh_term>Nociceptin</mesh_term>
	<mesh_term>Nocistatin</mesh_term>
	<criteria>For septic patient ; 1 . Participant willing able give inform consent participation study , lack capacity , next kin advocate willing able give assent participation study . Must able read understand English . 2 . Male Female , age 18 year . 3 . Diagnosed sepsis admit intensive care unit . 4 . Able ( Investigators opinion ) willing comply study requirement . 5 . Willing allow General Practitioner consultant , appropriate , notified participation study . Healthy Volunteers ; 1 . Participant willing able give inform consent participation study . Must able read understand English . 2 . Male Female , age 18 year 3 . In good health . 4 . Have course medication , whether prescribed overthecounter , four week first study dose individual dos final two week mild analgesia , vitamins mineral supplement , female , oral contraceptive 5 . Able ( Investigators opinion ) willing comply study requirement . 6 . Willing allow General Practitioner consultant , appropriate , notified participation study . 1 . Conditions may make phlebotomy hazardous participant ( significant bleeding disorder anaemia , allergy ) , investigator ( blood viral infection ) . 2 . Any significant disease disorder , opinion Investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study . 3 . Participants participate another research study involve investigational product past 12 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>